HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: The influence of the tumor microenvironment
Article first published online: 8 JUN 2012
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
European Journal of Immunology
Volume 42, Issue 6, pages 1599–1608, June 2012
How to Cite
Zilberman, S., Schenowitz, C., Agaugué, S., Favier, B., Riteau, B., Rouzier, R., Carosella, E. D., Rouas-Freiss, N. and Menier, C. (2012), HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: The influence of the tumor microenvironment. Eur. J. Immunol., 42: 1599–1608. doi: 10.1002/eji.201141761
- Issue published online: 8 JUN 2012
- Article first published online: 8 JUN 2012
- Manuscript Accepted: 1 MAR 2012
- Manuscript Revised: 27 FEB 2012
- Manuscript Received: 16 MAY 2011
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
|eji2274-sup-0001-s1.pdf||179K||Figure 1. Analysis of HLA-G1 protein expression and function in ®2m-deficient FO-1 melanoma cells.|
|eji2274-sup-0001-s1.pdf||179K||Figure 2. Effect of IL-10, VEGF, bFGF, EGF, and SCF on HLA-G1 expression by Fon+ cells.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.